Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for its generic drug, injectable Cefazolin Sodium (0.5g, 1.0g), which has passed the quality and therapeutic consistency evaluation. The approval marks a significant milestone for the company in adhering to high standards of drug production and contributes to its reputation in the pharmaceutical industry.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
